295
Participants
Start Date
February 28, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
Aripiprazole and aripiprazole once-monthly
Oral aripiprazole tablets according to Summary of Product Characteristics (SmPC)/United States Prescription Information (USPI) daily for 4 weeks followed by the 1st aripiprazole intramuscular (IM) injection at the end of Week 4. Oral tablets were taken for 2 more weeks after the 1st injection. Starting at the end of Week 8, additional injections were given every 4 weeks until Week 24.
Paliperidone and paliperidone palmitate
Oral paliperidone tablets according to SmPC/USPI daily for 3 weeks followed by 2 paliperidone palmitate IM injections at Weeks 3 and 4, respectively. Starting at the end of Week 8, additional injections were given every 4 weeks until Week 24.
US002, Los Angeles
US006, San Diego
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
H. Lundbeck A/S
INDUSTRY